Evidence map›Paper›PMID 31710650›Full record

ArticlePLoS pathogens2019

NEDD4 family ubiquitin ligases associate with LCMV Z's PPXY domain and are required for virus budding, but not via direct ubiquitination of Z.

Christopher M Ziegler, Loan Dang, Philip Eisenhauer, Jamie A Kelly, Benjamin R King, Joseph P Klaus, Inessa Manuelyan, Ethan B Mattice, David J Shirley, Marion E Weir and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Sirtuin 1 Is Required for Optimal Mammarenavirus Multiplication.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Adaptors as the regulators of HECT ubiquitin ligases.Cell death and differentiation · 2021
    Review
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Christopher M ZieglerDepartment of Medicine, Division of Immunobiology, University of Vermont, Burlington, Vermont, United States of America.ORCID 0000-0002-1252-654X
Loan DangDepartment of Medicine, Division of Immunobiology, University of Vermont, Burlington, Vermont, United States of America.ORCID 0000-0002-7232-5627
Philip EisenhauerDepartment of Medicine, Division of Immunobiology, University of Vermont, Burlington, Vermont, United States of America.
Jamie A KellyDepartment of Medicine, Division of Immunobiology, University of Vermont, Burlington, Vermont, United States of America.ORCID 0000-0003-2416-2496
Benjamin R KingDepartment of Medicine, Division of Immunobiology, University of Vermont, Burlington, Vermont, United States of America.ORCID 0000-0003-2919-3961
Joseph P KlausDepartment of Medicine, Division of Immunobiology, University of Vermont, Burlington, Vermont, United States of America.
Inessa ManuelyanDepartment of Medicine, Division of Immunobiology, University of Vermont, Burlington, Vermont, United States of America.ORCID 0000-0002-8697-7239
Ethan B MatticeCellular, Molecular and Biomedical Sciences Graduate Program, University of Vermont, Burlington, Vermont, United States of America.ORCID 0000-0002-3002-2193
David J ShirleyIxis LLC, Data Science Division, Burlington, Vermont, United States of America.ORCID 0000-0003-4529-0403
Marion E WeirDepartment of Biology, University of Vermont, Burlington, Vermont, United States of America.ORCID 0000-0002-6144-0531
Emily A BruceDepartment of Medicine, Division of Immunobiology, University of Vermont, Burlington, Vermont, United States of America.ORCID 0000-0001-8391-370X
Bryan A BallifDepartment of Biology, University of Vermont, Burlington, Vermont, United States of America.ORCID 0000-0001-7650-3817
Jason BottenDepartment of Medicine, Division of Immunobiology, University of Vermont, Burlington, Vermont, United States of America.ORCID 0000-0001-6839-0306
University of Vermont · US

Funding

Vaccines and Diagnostics TrialsU54AI065359 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI BARBOUR, ALAN G. · 2005 to 2013
$88.8M
Vermont INBRE Administrative Supplement 2024 AWD 118P20GM103449 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI CHRISTOPHER S FRANCKLYN · 2012 to 2026
$58.4M
VERMONT IMMUNOBIOLOIGY/ INFECTIOUS DISEASES CENTERP20RR021905 · NCRR · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BUDD, RALPH C · 2006 to 2011
$14.5M
Vermont Immunology/Infectious Diseases CenterP30GM118228 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BUDD, RALPH C · 2016 to 2021
$6.8M
Multidisciplinary Training in Lung BiologyT32HL076122 · NHLBI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI IRVIN, CHARLES G, POYNTER, MATTHEW E · 2004 to 2023
$6.1M
Vermont Immunology/Infectious Diseases Training GrantT32AI055402 · NIAID · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI GARY E WARD · 2005 to 2026
$2.7M
Therapeutic antibodies for treatment of hantavirus cardiopulmonary syndromeR41AI132047 · NIAID · CELDARA MEDICAL, LLC · PI BOTTEN, JASON W., FANGER, MICHAEL W · 2017 to 2018
$800k
Identification of Novel Arenavirus Protein-Host Cellular Protein InteractionsR21AI088059 · NIAID · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BOTTEN, JASON W. · 2010 to 2011
$416k
NCRR NIH HHS P20 RR021905NHLBI NIH HHS T32 HL076122NIAID NIH HHS R21 AI088059NIAID NIH HHS R41 AI132047NIAID NIH HHS T32 AI055402NIAID NIH HHS U54 AI065359NIGMS NIH HHS P20 GM103449NIGMS NIH HHS P30 GM118228
6 · The paper itself

Abstract

Viral late domains are used by many viruses to recruit the cellular endosomal sorting complex required for transport (ESCRT) to mediate membrane scission during viral budding. Unlike the P(S/T)AP and YPX(1-3)L late domains, which interact directly with the ESCRT proteins Tsg101 and ALIX, the molecular linkage connecting the PPXY late domain to ESCRT proteins is unclear. The mammarenavirus lymphocytic choriomeningitis virus (LCMV) matrix protein, Z, contains only one late domain, PPXY. We previously found that this domain in LCMV Z, as well as the ESCRT pathway, are required for the release of defective interfering (DI) particles but not infectious virus. To better understand the molecular mechanism of ESCRT recruitment by the PPXY late domain, affinity purification-mass spectrometry was used to identify host proteins that interact with the Z proteins of the Old World mammarenaviruses LCMV and Lassa virus. Several Nedd4 family E3 ubiquitin ligases interact with these matrix proteins and in the case of LCMV Z, the interaction was PPXY-dependent. We demonstrated that these ligases directly ubiquitinate LCMV Z and mapped the specific lysine residues modified. A recombinant LCMV containing a Z that cannot be ubiquitinated maintained its ability to produce both infectious virus and DI particles, suggesting that direct ubiquitination of LCMV Z alone is insufficient for recruiting ESCRT proteins to mediate virus release. However, Nedd4 ligases appear to be important for DI particle release suggesting that ubiquitination of targets other than the Z protein itself is required for efficient viral ESCRT recruitment.

Indexed as

UbiquitinationVirus AssemblyVirus ReplicationHumansIntracellular Signaling Peptides and ProteinsLymphocytic ChoriomeningitisLymphocytic choriomeningitis virusNedd4 Ubiquitin Protein LigasesProtein DomainsProtein Interaction Domains and MotifsIntracellular Signaling Peptides and ProteinsNedd4 Ubiquitin Protein Ligasesp11 Z protein, Lymphocytic choriomeningitis virus

Identifiers

PMID31710650
PMCPMC6874086
OpenAlexW2988174100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.